Standard BioTools Inc. Revenue from Related Parties
Standard BioTools Inc. (LAB) reported Revenue from Related Parties of $46.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-12.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2013-03-12
- Standard BioTools Inc. revenue from related parties for fiscal 2011 was $46.00K, a 95.82% decline from fiscal 2010.
- Standard BioTools Inc. revenue from related parties for fiscal 2010 was $1.10M, a 27.73% decline from fiscal 2009.
- Standard BioTools Inc. revenue from related parties for fiscal 2009 was $1.52M.
| Period end | Revenue from Related Parties 12 month | Revenue from Related Parties 12 month as first filed |
|---|---|---|
| 2011-12-31 | $46.00K 10-K · filed 2013-03-12 | |
| 2010-12-31 | $1.10M 10-K · filed 2013-03-12 | $1.10M 10-K · filed 2012-03-26 |
| 2009-12-31 | $1.52M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |